Science Jobs at Miltenyi Biotec

With over 20 years of experience we are pioneering cellular immunotherapy, enabling and developing innovative and promising cellular immunotherapy approaches for cancer and degenerative diseases.

Covering the whole process from basic research, technologies and applications to therapies, we conduct analysis in the fields of neoantigens and tumor-infiltrating lymphocytes, while studying the tumor microenvironment and its escape mechanisms. This helps us understand underlying mechanisms and turn knowledge into therapies.

With a strong focus on CAR technology, we want to create an innovation pipeline of new CAR technologies, targets and therapies, improve the safety and efficacy of our CAR T cell pharmaceutical and bring its design and manufacturing to the next level. Thus, we constantly strive to develop new approaches for gene engineering and delivery, cell processing and more, and to embed our knowledge in our CliniMACS Prodigy® platform for fully-automated and scalable cell manufacturing procedures.

With an agile mind and scientific curiosity, you can support us in gaining more knowledge about cellular immunotherapies, improving existing therapy and rolling out new concepts for different kind of tumors. Add in your self-motivated and eager-to-learn personality and let your work really make a difference.

This research field is a great venture and Miltenyi Biotec contributes to it by forging new concepts and tools to turn stem cells into relevant candidates for cellular therapies to treat a wide range of common diseases without known cures, like Parkinson’s, diabetes, chronic heart failure and retinal disease.

To enable a successful clinical translation, many questions need to be resolved and obstacles overcome. Hence, one of our biggest challenges is to develop a meaningful and cost-effective manufacturing concept.

A highly motivated and skilled team with a broad range of expertise welcomes every new and inquiring mind in this rapidly advancing and fascinating research field. 

Your passion and curiosity for science are enabling the next wave of Miltenyi Biotec´s success stories. 

Nowadays, there is barely an experiment running that does not use recombinant proteins. Miltenyi Biotec is an expert in this field. For over 20 years, we have been producing recombinant proteins for research and clinical use, developing them from cloning to expression, purification to characterization. 

As each protein is different, we use a variety of methods and state-of-the art devices, while continuously developing and establishing new methods and technologies. With the protein being of use in almost every Miltenyi Group development project, as a member of this team you are connected throughout the entire R&D department – and beyond. 

CAR binders, CAR detection reagents based on recombinant antigens, and MACS® GMP Cytokines for the culture of CAR T and CAR NK cells are just the most obvious contributions this team makes to our “Make cancer history” mission. If you are up for big challenges – like balancing between top-notch product quality and the shortest possible development times – and seek a break from run-of-the-mill routines, then our dynamic and open-minded team looks forward to welcoming you and your ideas, while giving you the breathing room to become a leading expert.

With today´s progress in science and cutting-edge technology, research projects create huge amounts of data that can only help changing lives when analyzed correctly. Our Bioinformatics Team deals with the implementations for big data, the development of data analysis methods and software for life science and clinical data. This includes cutting-edge methods like machine learning, data quality control systems, statistical analysis pipelines, data visualization and handling to answer questions that lead to new therapeutics being developed. 

The different types of data including various -omics data, complex images and flow cytometry data are produced in-house and in collaboration with other scientists and clinicians. Data analyses by our bioinformaticians represent a crucial puzzle piece in our mission to “Make cancer history” by providing a more comprehensive picture of disease and in helping us stratify patients in order to suggest personalized therapies.

Join a one-of-a-kind team of biologists, bioinformaticians and computer – and bring your ideas with you!

On our Chemical Biology Team we develop tools and kits for researchers to isolate and analyze their target cell population. 

The very core of almost every technology developed by Miltenyi Biotec is antibodies linked to fluorochromes, magnetic beads, enzymes and more. Our researchers are dedicated to perfecting all these different types of antibody conjugates, finding new ways to synthesize novel and brighter fluorochromes, developing new buffers and accessories for our technologies, and to bringing our bead-based technologies to the next level. Their aim is to provide solutions and optimized workflows for our customers in academia, industry and health care institutions.

Here, chemists and biologists work hand in hand, leveraging their collective expertise in highly interdisciplinary teams to create cutting-edge technology and clinical applications. Join us in fusing chemistry and biology to make cancer history. 

Using our expertise in cell analysis we are entering the field of in vitro diagnostics (IVD). Beside the growing number of antibodies that we are offering for diagnostic purposes, our researchers are continually developing new approaches to IVDs that contribute to the bigger “Make cancer history” picture. 

IVDs are an important part of our cell and gene therapy workflow. Miltenyi researchers focus on assays for assessing cellular product quality before administration and patient immunomonitoring after disbursement. Covering assays for bench-to-bedside as well bedside-to-bench applications, you will develop reagents and tools for scientists working in a highly regulated environment where quality control and monitoring assays are crucial for therapy efficacy. Hence, as one of the researchers in this division you not only are a lab expert but also ensure compliance with all the regulatory requirements.

You are at the interface of research and clinical applications, and the best reward for your hard work is to see the actual lives your developments might change. 

Isolating target cells or preparing samples is always just the first step of your experiment. What follows is the analysis of the cell population or tissue section. Our researchers develop new procedures and optimize existing methods for carrying it out. Whether via microscopy or flow cytometry or by cell sorting: accuracy is paramount.

We are developing novel products for sample preparation of tissues and organoids that will support light sheet microscopy. Our goal is to gain a very detailed 3D characterization of tissue structures to learn more about antigen distribution in whole tissues. Also, we use our MACSima™ Imaging Platform to perform simultaneous analysis of multiple markers on the same tissue structure. This helps scientists visualize the heterogeneity of marker expression in tumor tissue, which is crucial for developing novel cancer treatment strategies. 

Next to imaging techniques, flow cytometry is an important analysis tool and one of our key competences. Our scientists develop and improve applications, hardware and software for everything from basic research to diagnostics for cancers like leukemia and lymphoma. 

Join our team of interdisciplinary scientists and make valuable contributions to our cell analysis portfolio that spark groundbreaking scientific research worldwide.

We at Miltenyi Biotec know that good research starts with well-bred and meticulously-cared-for cells. Although this might sound obvious, it’s anything but. The preparation of cells – from a tissue to single-cell suspension, cell type isolation, and cell cultivation – belong to Miltenyi Biotec´s core business areas for over 30 years… but we aren’t stopping there.

Because we want our customers to achieve the best possible experimental conditions for their work, we need your support in developing new instruments, consumables, reagents and automated solutions to improve lab workflows worldwide. Miltenyi Biotec offers complete solutions: once the cell is isolated we provide the matching media, growth factors and much more.

Tumor tissue can be especially challenging. Engineers and scientists at Miltenyi Biotec are working on new dissociation techniques for fresh and fixed tumor tissue required for successful downstream applications.

Finding the optimal compromise between efficient tissue dissociation and epitope recovery for antigen binding is one of our main goals. Join us in enabling and optimizing cancer research and help make cancer history.